Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HETERO LABS LTD V

  • FDA Approval
  • Oct. 30, 2024, 13:10 UTC
  • 43
  • 0 comments

FDA approve PALBOCICLIB

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Oct. 30, 2024, 13:10 UTC
  • 49
  • 0 comments

FDA approve SITAGLIPTIN;METFORMIN HYDROCHLORIDE

Comment Full text

TEVA PHARMS INC

  • FDA Approval
  • Oct. 30, 2024, 13:00 UTC
  • 48
  • 0 comments

FDA approve GLYCEROL PHENYLBUTYRATE

Comment Full text

ORGANON

  • FDA Approval
  • Oct. 29, 2024, 17:28 UTC
  • 41
  • 0 comments

FDA approve ATORVASTATIN CALCIUM; EZETIMIBE

Comment Full text

AM REGENT

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 40
  • 0 comments

FDA approve HYDRALAZINE HYDROCHLORIDE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 42
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text

APOTEX

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 39
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text

ALEMBIC

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 41
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

NOVAST LABS

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 43
  • 0 comments

FDA approve PRAMIPEXOLE DIHYDROCHLORIDE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 41
  • 0 comments

FDA approve EZETIMIBE

Comment Full text
  • Previous
  • 279
  • 280
  • 281
  • 282
  • 283
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2016)
  • SEC News(184759)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122443)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin